Kelly Ripa Stars in Public Service Announcements for “QVC Presents Super Saturday LIVE,” Benefitting Ovarian Cancer Research Fund WEST CHESTER, Pa. (June 10, 2014) – Kelly Ripa is shopping to save lives as she fills up her bag with designer deals that will contribute to the cure for ovarian cancer. Ripa, one of the most … Continued
Posted by adavis on January 24, 2014 FOR IMMEDIATE RELEASE: January 24, 2014 Washington, DC—In response to a recent speech by Mike Huckabee, in which he stated that women use oral contraceptives because they “cannot control their libidos or their reproductive systems,” the Ovarian Cancer National Alliance issued the following statement from CEO Calaneet Balas: “In his quest … Continued
(May 6, 2014) Tumors use numerous mechanisms to escape detection and killing by the immune system. Results from OCRF-funded research, reported May 4, 2014 in the prestigious journal Nature Medicine, show that ovarian cancer cells (and others) establish a protective barrier that prevents anti-tumor immune responses by using tumor-associated blood vessels to kill immune cells. … Continued
This week, the Ovarian Cancer National Alliance submitted comments to the Food and Drug Administration (FDA) about a proposed Guidance for Industry that could have the effect of limiting patient access to “off label” oncology drugs. In cancer, many people are prescribed treatments approved for other uses, but not currently approved for a particular disease. … Continued
This month, we celebrate Liz Tilberis, beloved former president of OCRF and editor-in-chief of Harper's Bazaar.
Designer Charity Sale expands to the West Coast in celebration of OCRF’S 20th Anniversary; Offers Day-Long Luxury Experiences for the Whole Family Los Angeles, CA (April 7, 2014) – Rachel Zoe and Molly Sims with their husbands Rodger Berman and Scott Stuber will host Ovarian Cancer Research Fund’s 1st Annual Super Saturday LA. The event, … Continued
(April 7, 2014) A group of OCRF-funded researchers at Baylor College of Medicine have found a “fusion gene” that is present in 20% of high grade serous ovarian cancer patients. The finding, which was published in PLOS Genetics, was supported in part by OCRF grants to Martin Matzuk, MD, PhD, Shannon Hawkins, MD, PhD, and … Continued
(April 1, 2014) Ovarian Cancer Research Fund is now accepting Letters of Intent for its three research grant programs. Letters of Intent must be submitted by May 6, 2014 at 5:00pm ET.
OCRF-funded research at UC Davis have verified that glycans (sugars attached to proteins) can be used to identify ovarian cancer. The study was published online in the journal Cancer Epidemiology, Biomarkers & Prevention. “This is one of many papers we’ve done to see if glycans can distinguish between women who have ovarian cancer and those who … Continued
Program Gynecologic Cancer Patients to Receive New Support in Providence, New Orleans, Houston and The Bronx WEST CHESTER, Pa (March 10, 2014) —Ovarian Cancer Research Fund (OCRF) and QVC today announced four new Woman to Woman grant recipients: Women & Infants Hospital of Rhode Island, Providence, RI; Tulane Cancer Center, New Orleans, LA; Baylor College … Continued
FOR IMMEDIATE RELEASE: February 7, 2014 Further Study Needed Before Clinical Recommendations Change Washington, DC—A study published yesterday by the National Institutes of Health found that women who took aspirin on a daily basis had a 20 percent reduction in risk of ovarian cancer. The Ovarian Cancer National Alliance released the following statement in response … Continued
(January 30, 2014) OCRF grantee Yin Wang, PhD, led research which found that PKC iota signaling plays an important role in ovarian cancer development. The research, which was published in Molecular Cancer Research, also found that Auranofin, a small molecular compound, shows potential for treating ovarian cancer. The research study was funded in part by … Continued
Get email updates about research news, action alerts, and ways to join the fight.
